Sabbagh N - Search Results

1

Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.

Legrand-Andréoletti M, Stücker I, Marez D, Galais P, Cosme J, Sabbagh N, Spire C, Cenée S, Lafitte JJ, Beaune P, Broly F. Legrand-Andréoletti M, et al. Among authors: sabbagh n. Pharmacogenetics. 1998 Feb;8(1):7-14. doi: 10.1097/00008571-199802000-00002. Pharmacogenetics. 1998. PMID: 9511176

2

A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.

Broly F, Marez D, Lo Guidice JM, Sabbagh N, Legrand M, Boone P, Meyer UA. Broly F, et al. Among authors: sabbagh n. Hum Genet. 1995 Nov;96(5):601-3. doi: 10.1007/BF00197419. Hum Genet. 1995. PMID: 8530011

3

A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype.

Marez D, Sabbagh N, Legrand M, Lo-Guidice JM, Boone P, Broly F. Marez D, et al. Among authors: sabbagh n. Pharmacogenetics. 1995 Oct;5(5):305-11. doi: 10.1097/00008571-199510000-00006. Pharmacogenetics. 1995. PMID: 8563771

4

An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine.

Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F. Marez D, et al. Among authors: sabbagh n. Hum Genet. 1996 May;97(5):668-70. doi: 10.1007/BF02281880. Hum Genet. 1996. PMID: 8655150

5

An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.

Broly F, Marez D, Sabbagh N, Legrand M, Millecamps S, Lo Guidice JM, Boone P, Meyer UA. Broly F, et al. Among authors: sabbagh n. Pharmacogenetics. 1995 Dec;5(6):373-84. doi: 10.1097/00008571-199512000-00006. Pharmacogenetics. 1995. PMID: 8747409

6

Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility.

Legrand M, Stucker I, Marez D, Sabbagh N, Lo-Guidice JM, Broly F. Legrand M, et al. Among authors: sabbagh n. Carcinogenesis. 1996 Oct;17(10):2267-9. doi: 10.1093/carcin/17.10.2267. Carcinogenesis. 1996. PMID: 8895499

7

NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.

Sabbagh N, Delaporte E, Marez D, Lo-Guidice JM, Piette F, Broly F. Sabbagh N, et al. Pharmacogenetics. 1997 Apr;7(2):131-5. doi: 10.1097/00008571-199704000-00006. Pharmacogenetics. 1997. PMID: 9170150

8

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F. Marez D, et al. Among authors: sabbagh n. Pharmacogenetics. 1997 Jun;7(3):193-202. doi: 10.1097/00008571-199706000-00004. Pharmacogenetics. 1997. PMID: 9241659

9

Evidence for CYP2D6 expression in human lung.

Guidice JM, Marez D, Sabbagh N, Legrand-Andreoletti M, Spire C, Alcaïde E, Lafitte JJ, Broly F. Guidice JM, et al. Among authors: sabbagh n. Biochem Biophys Res Commun. 1997 Dec 8;241(1):79-85. doi: 10.1006/bbrc.1997.7775. Biochem Biophys Res Commun. 1997. PMID: 9405237

10

Genetic analysis of the cytochrome P450 CYP2D6 polymorphism in patients with systemic lupus erythematosus.

Sabbagh N, Marez D, Queyrel V, Lo Guidice JM, Spire C, Vanhille P, Jörgensen C, Hachulla E, Broly F. Sabbagh N, et al. Pharmacogenetics. 1998 Jun;8(3):191-4. Pharmacogenetics. 1998. PMID: 9682264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters